Showing posts with label HPA. Show all posts
Showing posts with label HPA. Show all posts

HPA: Flu Activity In The UK

 

 

# 6820

 


While the United States and Canada have reported an early start to the flu season this year, influenza has yet to take off in Hong Kong (see latest Flu Express (Week 52, 2012), and in the UK and parts of Europe the flu season is just now starting to pick up. 

 

 

image

The RED LINE indicates this year’s activity, compared to previous years.  The Blue Line indicates the unusually severe 1999-2000 flu season.

 

 

This latest flu updates from the HPA.

 

HPA National Influenza Report

Report published 3 January 2013

Figures (including all those found in this report) displaying data from these schemes are available to download as a pdf file:

HPA Weekly National Influenza Graphs (PDF, 713 KB)

PDF versions of previous reports are available on the archive page.

This week's report is available as a pdf:

HPA National Influenza Report - week 1 (2013) (PDF, 665 KB)

A summary report will be published weekly. For further information on the surveillance schemes mentioned in this report, please see the Sources of UK Flu Data page.

Increases continue to be seen for several indicators of influenza activity. A letter has been issued to the NHS that GPs may now prescribe antiviral medicines for the prophylaxis and treatment of influenza in accordance with NICE guidance.

 

Flu activity update: 3 January 2013

3 January 2013

Latest figures from the Health Protection Agency (HPA) up to 30 December 2012 show that flu activity continues to increase based on a number of indicators, including GP consultation rates in England and the proportion of calls to NHS Direct.

 

The latest figures show that GP consultation rates have increased slightly from 27.4 per 100,000 in week 51 to 32.7 per 100,000 in week 52 ending on 30 December. Meanwhile, 2.1% of the calls received by NHS Direct concerned influenza compared to 1.6% in week 51.

 

Professor John Watson, head of the respiratory disease department at the HPA said:

 

“Over the Christmas period we have seen a slight rise in flu activity across several of our indicators in line with the trend we expect to see at this time of year.

 

“However, the latest data should be interpreted with caution due to GP practices being closed on the bank holidays which may have impacted on GP consultation rates.

(Continue . . . )

 

 

Elsewhere in Europe, the most recent EuroFlu report states:

 

Influenza activity is increasing slowly in the WHO European Region

Summary, week 51/2012

Influenza activity is slowly increasing with more countries in different parts of the Region reporting sporadic co-circulation of influenza A(H1N1)pdm09, A(H3N2) and type B viruses. This week the reporting of influenza surveillance data is incomplete due to the Christmas holidays. This is reflected in the lower number of testing performed. However the percentage of influenza-positive samples from both sentinel and non-sentinel sources are similar to last week. The number of reported hospitalizations due to severe acute respiratory infection (SARI) remains similar to that seen in the previous several weeks: 1 influenza detection was reported (influenza B).

»» Read More

HPA Norovirus Update

norovirus 3D structure

Norovirus – Credit HPA

 


# 6817

 

The UK’s HPA has released a new update on their busy norovirus season, which has prompted headlines in British papers announcing more than One Million Cases this year.

 

That number is an extrapolation, based on the assumption that there are 288 uncounted cases for every case officially diagnosed.

 

So take it as an estimate, not a precise count.  Still, reported cases of norovirus are well ahead of last year’s numbers across the UK.

 

 

HPA update on seasonal norovirus activity: 2 January 2013

2 January 2013

Latest figures from the Health Protection Agency (HPA) show there have been 3,877 laboratory confirmed cases of norovirus this season (from week 27 to week 51 2012). The latest figures are 72 per cent higher than the number of cases reported at this point last year, when there were 2,255 cases.

 

During the Christmas period there is typically a drop in the number of laboratory reports. In previous norovirus seasons the general trend is that cases increase in the New Year and we expect to see cases rise again over the next few weeks.

 

During the two weeks up to 30 December there were 29 hospital outbreaks reported, compared to 70 in the previous fortnight, bringing the total of outbreaks for the season to 590.

 

Cases of norovirus have risen earlier than expected this winter season and this is a trend that has been seen across Europe and other parts of the world. It has not yet been determined why this has been the case and activity varies significantly from year to year.

 

John Harris, an expert in norovirus from the HPA said: “As we have seen in previous years there has been a dip in the number of confirmed laboratory reports owing to the Christmas and New Year period. However, in line with other norovirus seasons we will expect to see an increase in the number of laboratory reports in the next few weeks.

 

“Norovirus is very contagious, and anyone who has had it knows it is very unpleasant. If you think you may have the illness then it is important to maintain good hand hygiene to help prevent it spreading. We also advise that people stay away from hospitals, schools and care homes as these environments are particularly prone to outbreaks.”

 

Norovirus can be transmitted by contact with contaminated surfaces or objects, by contact with an infected person, or by the consumption of contaminated food or water. Symptoms of norovirus include a sudden onset of vomiting and/or diarrhoea. Some people may have a temperature, headache and stomach cramps. The illness usually resolves in one or two days and there are no long-term effects.

Ends

Notes to editors

  1. Indications from Europe and Japan are that norovirus activity also started to increase early. In Australia the norovirus season also peaks during the winter but this season it has gone on longer than usual and they are seeing cases into their summer. The HPA is following up with colleagues internationally.
  2. The number of laboratory confirmed cases represents just a fraction of the actual amount of norovirus activity as it is estimated that for each confirmed case, there are a further 288 unreported cases, as the vast majority of those affected do not seek healthcare services in response to their illness. Data from The Infectious Intestinal Diseases II (IID II) report can be found at the Food Standards Agency website [external link].

(Continue . . . )

 

 

For more on noroviruses, you may wish to revisit the following blogs.

 
Vomiting Larry And His Aerosolized Norovirus
An Unwanted Lagniappe From The Kitchen
UK: Norovirus Season Starts Early
»» Read More

HPA: Whooping Cough Cases Remain High

image

Credit CDC


# 5798

 

Updating a story from late in November (see UK: Three Whooping Cough Deaths In October), while the number of new UK Pertussis cases reported in November dropped over the previous month, they still remain well above average.

 

The HPA released the following update this morning.

 

Whooping cough cases remain high

21 December 2012

Figures published by the Health Protection Agency (HPA) today show that cases of whooping cough have continued at high levels during November with 1,080 confirmed cases reported for England and Wales, bringing the total number of cases so far this year to 8,819*. No deaths were reported in November.

 

The total of 1,080 cases reported during November represents a decrease from October when 1,631 cases were reported for England and Wales, which is the first time we’ve seen a decrease in monthly numbers since the current outbreak began in the middle of 2011. However, a decrease in cases is usually seen at this time of year so this does not necessarily represent the end of this severe outbreak.

 

At the end of September, the Department of Health announced that pregnant women would be offered whooping cough vaccination to protect their newborn babies, who do not usually start their vaccinations against whooping cough until they are two months of age. The aim of the vaccination programme is to help to boost the short term immunity passed on by women to their babies while they are still in the womb.

 

It is too soon for this vaccination campaign to have had an impact on the case numbers we are seeing, however, the Department of Health recently reported an uptake of around 40 per cent in pregnant women.

 

Dr Gayatri Amirthalingam, consultant epidemiologist for immunisation at the HPA, said: “The November figures show a welcome decrease of whooping cough cases since October. However, it is very important to note that we usually see a reduction in cases of whooping cough at this time of year so this decrease is in line with normal seasonal patterns.

 

“The recent announcement that at least 40 per cent of pregnant women received the whooping cough vaccine in the first month of the programme is very encouraging. We would like to remind pregnant women how serious this infection can be in young babies and how it can in some cases cause death. Vaccination between 28 and 38 weeks of pregnancy should offer babies the best protection against whooping cough before they receive their own vaccines.

 

“As well as this, parents should ensure their children are vaccinated against whooping cough on time, even babies of women who’ve had the vaccine in pregnancy – this is to continue their baby’s protection through childhood."

 

Whooping cough, also known as pertussis, affects all ages. Young infants are at highest risk of severe complications and death from whooping cough as babies do not complete vaccination until they are around four months old. In older children and adults whooping cough can be an unpleasant illness but it does not usually lead to serious complications. Whooping cough is a highly infectious bacterial disease which spreads when a person with the infection coughs and sheds the bacteria which is then inhaled by another person.

 

Dr Amirthalingam continues, “Parents should also be alert to the signs and symptoms of whooping cough – which include severe coughing fits accompanied by the characteristic “whoop” sound in young children but as a prolonged cough in older children or adults.”

(Continue . . . )

 

 

 

The reasons behind the spike in Pertussis cases (not only in the UK, but in the U.S., Australia, and elsewhere) are complex, and not completely understood, but some factors may include:

 

  • lower vaccination uptakes
  • the move away from whole cell pertussis vaccines to safer – but less broadly protective  - acellular vaccines in the 1990s
  • evolutionary changes in the Bordetella pertussis bacteria.

 

Recent evidence published in the NEJM suggests that protection from the newer acellular pertussis vaccine – introduced in the early 1990s – may wane sooner than previously suspected. 

 

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

Nicola P. Klein, M.D., Ph.D., Joan Bartlett, M.P.H., M.P.P., Ali Rowhani-Rahbar, M.D., M.P.H., Ph.D., Bruce Fireman, M.A., and Roger Baxter, M.D.

N Engl J Med 2012; 367:1012-1019 September 13, 2012DOI: 10.1056/NEJMoa1200850

 

 

While not 100% perfect, the Pertussis vaccine remains the best way to prevent Whooping Cough.

 

As noted above, the rise in whooping cough isn’t just a problem in the UK.  The graphic below shows that – except for California – every state in the union has reported an increase in Pertussis cases this year over 2011 (through week 46). 

 

image

For more on the prevention of Whooping Cough, and the role of the Tdap vaccine, visit:

 

http://www.cdc.gov/pertussis/

 

image

»» Read More

UK: Three Whooping Cough Deaths In October

 

image

Credit CDC

 


# 6749

 

Whooping cough has been in the news (and in this blog) a lot this week (see Safety Of Tdap Vaccine In Older Patients and Waning Pertussis Vaccine Effectiveness Over Time), and with an announcement overnight from the HPA, today I go for the hat trick.

 

Last month (see The UK’s Whooping Cough Outbreak) we looked at the rising pertussis numbers in the UK, and the announcement that that pregnant women would be offered the Pertussis vaccine in order to protect their newborns, who cannot be vaccinated until they are 2 – 4 months of age.


 

The latest announcement from the HPA indicates that during the month of October more than 1,600 additional cases of Whooping cough were reported in England and Wales, resulting in 3 infant deaths.  This brings the death toll in 2012 to 13.

 

As you can see by the chart below, Pertussis in 2012 is running roughly 10 times the rate seen in recent years.

 

image

 

The reasons behind this latest spike in Pertussis cases are complex, and not completely understood, but some factors may include:

  • lower vaccination uptakes
  • the move away from whole cell pertussis vaccines to safer – but less broadly protective  - acellular vaccines in the 1990s
  • evolutionary changes in the Bordetella pertussis bacteria.

 

Here are some excerpts from the HPA’s press release:

 

Whooping cough cases continue to increase

30 November 2012

Figures published by the Health Protection Agency (HPA) today reveal 1,614 cases of whooping cough were reported in England and Wales in October 2012, bringing the total number of cases so far this year to 7,728*.

 

The total number of cases so far in 2012 (up to end of October) is nearly ten times higher than for the same period in 2008, the last ‘peak’ year before this current outbreak, when 797 cases were reported. There have been three deaths in infants with laboratory confirmed whooping cough reported in October bringing the total number of deaths in this age group so far this year to 13.

 

At the end of September, the Department of Health announced that pregnant women would be offered whooping cough vaccination to protect their newborn babies, who do not usually start their vaccinations against whooping cough until they are two months of age. The aim of the vaccination programme is to help to boost the short term immunity passed on by women to their babies while they are still in the womb.

 

Dr Gayatri Amirthalingam, consultant epidemiologist for immunisation at the HPA, said: “The October figures show a continuing rise in the overall number of whooping cough cases. While there has been a decline in the number of infant cases it’s important to emphasise that it’s too early to see any impact from the pregnancy vaccination programme. Working with the Department of Health we are continuing to carefully monitor whooping cough activity to evaluate the success of the programme.

 

“We strongly recommend all pregnant women take up the offer of vaccination. Parents should also ensure their children are vaccinated against whooping cough on time, even babies of women who’ve had the vaccine in pregnancy – this is to continue their baby’s protection through childhood. Parents should also be alert to the signs and symptoms of whooping cough – which include severe coughing fits accompanied by the characteristic “whoop” sound in young children but as a prolonged cough in older children or adults. It is also advisable to keep babies away from older siblings or adults who have the infection.”

 

Whooping cough, also known as pertussis, affects all ages. Young infants are at highest risk of severe complications and death from whooping cough as babies do not complete vaccination until they are around four months old. In older children and adults whooping cough can be an unpleasant illness but it does not usually lead to serious complications. Whooping cough is a highly infectious bacterial disease which spreads when a person with the infection coughs and sheds the bacteria which is then inhaled by another person.

(Continue . . . )

 

 

For more information, the CDC maintains an extensive Whooping Cough website, including audio files designed to help you identify the often distinctive `whooping’ sound made by those infected.

 

Pertussis (Whooping Cough)

Mother holding baby.

Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis.

Pertussis is known for uncontrollable, violent coughing which often makes it hard to breathe. After fits of many coughs, someone with pertussis often needs to take deep breathes which result in a "whooping" sound. Pertussis most commonly affects infants and young children and can be fatal, especially in babies less than 1 year of age.

(Continue . . . )

»» Read More

UK: Norovirus Season Starts Early

image

80% of Norovirus Outbreaks occur between November & April - Credit CDC 

 


# 6710

 

 

Whether you call it Norwalk or Norovirus – the more descriptive `Winter Vomiting Bug’, or the less accurate `stomach flu’  - the virus behind millions of cases of gastroenteritis each year can pack more misery into 72 hours than should be allowed by law.

 

Long the scourge of crowded institutions - like nursing homes, cruise ships, hospitals and schools - the virus also circulates readily in the community, taking advantage of low levels of human immunity and its ease of spread.

 

After exposure and a short incubation period (12-24 hours), the victim usually experiences nausea, frequent vomiting & diarrhea, and stomach pain – and may also experience headache, fever, and body aches.

 

The illness generally runs its course in 1 to 3 (very long) days, and most people recover.

 

But among those who are aged or infirmed, the virus can take a heavy toll. According to the CDC, each year the norovirus:

 

  • causes about 21 million cases of acute gastroenteritis (inflammation of the stomach or intestines or both)
  • contributes to about 70,000 hospitalizations and 800 deaths, mostly among young children and the elderly

 

Last month in JAMA, a study of 407 norovirus outbreaks across 308 nursing homes showed an 11% increase in fatalities during times when a facility was experiencing an outbreak.

 

JAMA. 2012 Oct 24;308(16):1668-75.

Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010.

Trivedi TK, DeSalvo T, Lee L, Palumbo A, Moll M, Curns A, Hall AJ, Patel M, Parashar UD, Lopman BA.

 

A short (2 minute) video on this paper may be viewed below. Among their recommendations, it is important to identify an outbreak early, take preventative measures, and nursing staff who become infected should not return to work until at least 48 hours after their symptoms have abated.

 

 

 

Already this winter, I’m aware of a couple of outbreaks here in Central Florida, and in the post-hurricane Sandy recovery, we’ve media reports that Viral outbreak at Hurricane Sandy evacuation shelter shuts 3 Brooklyn schools.

 

And from the UK today,  reports that their `winter vomiting bug season’ has gotten off to an early start.

 

Stomach flu earlier, worse in Britain

Published: Nov. 11, 2012 at 12:35 AM

LONDON, Nov. 11 (UPI) -- Norovirus, or the stomach flu, is 27 percent higher in Britain than at the same time last year and six weeks earlier than usual, health officials say.

(Continue . . .)

 

Earlier this week, the HPA posted the following notice on their Syndromic Surveillance site, indicating reports of vomiting were elevated, suggesting `community-based norovirus activity’.

 

image

 

One of the keys to prevention is good hand hygiene.

 

Unfortunately, unlike with many other bacteria and viruses, alcohol gel doesn’t do a particularly good job of killing the virus, as we discussed last year in  CMAJ: Hand Sanitizers May Be `Suboptimal’ For Preventing Norovirus.

 

Which makes a good old fashion hand scrubbing with soap and water the best preventative.

 

The primary method of infection is via the fecal-oral route. The CDC describes it this way:

 

Norovirus and Food

Norovirus is a leading cause of disease from contaminated foods in the United States. Foods that are most commonly involved in foodborne norovirus outbreaks include leafy greens (such as lettuce), fresh fruits, and shellfish (such as oysters). However, any food item that is served raw or handled after being cooked can become contaminated with noroviruses.

Norovirus Spreads Quickly

Norovirus can spread quickly from person to person in crowded, closed places like long-term care facilities, daycare centers, schools, hotels, and cruise ships. Noroviruses can also be a major cause of gastroenteritis in restaurants and catered-meal settings if contaminated food is served.

 

The viruses are found in the vomit and stool of infected people. You can get it by

  • Eating food or drinking liquids that are contaminated with norovirus (someone gets stool or vomit on their hands, then touches food or drink).
  • Touching surfaces or objects contaminated with norovirus and then putting your hand or fingers in your mouth.
  • Having direct contact with a person who is infected with norovirus (for example, when caring for someone with norovirus or sharing foods or eating utensils with them).

People with norovirus illness are contagious from the moment they begin feeling sick until at least 3 days after they recover. But, some people may be contagious for even longer.

 

The role of direct aerosolized human-to-human transmission of norovirus remains a bit murky, although there are numerous anecdotal reports that suggest that it happens.

 

The CDC – in a an MMWR report from 2011 called Updated Norovirus Outbreak Management and Disease Prevention Guidelines describes transmission thusly:

 

Transmission

Norovirus is extremely contagious, with an estimated infectious dose as low as 18 viral particles (41), suggesting that approximately 5 billion infectious doses might be contained in each gram of feces during peak shedding. Humans are the only known reservoir for human norovirus infections, and transmission occurs by three general routes: person-to-person, foodborne, and waterborne.

 

Person-to-person transmission might occur directly through the fecal-oral route, by ingestion of aerosolized vomitus, or by indirect exposure via fomites or contaminated environmental surfaces.

 

The CDC recommends the following steps to protect yourself from the virus.

 

image

 

 

Good advice, but frankly - having already gone through at least one memorable bout with the virus - if I found myself caring for someone with Norovirus in my household, I’d take a few extra precautionary steps.

 

According to:

 

GUIDELINE FOR THE PREVENTION AND CONTROL OF NOROVIRUS GASTROENTERITIS OUTBREAKS IN HEALTHCARE SETTINGS

Taranisia MacCannell, PhD, MSc ; Craig A. Umscheid, MD, MSCE ; Rajender K. Agarwal, MD, MPH ; Ingi Lee, MD, MSCE ; Gretchen Kuntz, MSW, MSLIS ;Kurt B. Stevenson, MD, MPH 3 and the Healthcare Infection Control Practices Advisory Committee (HICPAC)

(EXCERPT)

PERSONAL PROTECTIVE EQUIPMENT

23. If norovirus infection is suspected, adherence to PPE use according to Contact and Standard Precautions is recommended for individuals entering the patient care area (i.e., gowns and gloves upon entry) to reduce the likelihood of exposure to infectious vomitus or fecal material.    (Category IB) (Key Question 1.C.4)

  
24. Use a surgical or procedure mask and eye protection or a full face shield if there is an anticipated risk of splashes to the face during the care of patients, particularly among those who are vomiting. (Category IB) (Key Question 3.C.2.a) 


25. More research is needed to evaluate the utility of implementing Universal Gloving (e.g., routine use of gloves for all patient care) during norovirus outbreaks. (No recommendation/unresolved issue) 

 

One of the reasons I keep a generous supply of exam gloves, and surgical (& N95) masks in my emergency kit. 

 

And finally, earlier this year in Norovirus Sequelae we looked at  a new study appearing in Clinical Infectious Diseases that found a link between norovirus infection and ongoing gastrointestinal complaints.

 

Researchers looked at the records of more than 1700 military personnel who were treated for AGE (acute gastroenteritis) during three known norovirus outbreaks.

 

By comparing them to controls, they determined that those with a history of AGE were at increased risk of developing chronic gastrointestinal disorders.

 

Since this was a fairly small study, and some variability was detected in outcomes across the three outbreaks studied, more research will be needed to confirm their findings and to determine how long these after effects may persist.

 

Still, this is one virus that you want to avoid catching, if at all possible.

»» Read More

UK: The High Cost Of Getting High

 

image

Credit HPA

 

 

# 6707

 

For people who inject drugs (PWIDs) viral and bacterial infections are a constant danger, and can result in illness and even death. Hepatitis C, Hepatitis B, HIV, wound botulism, Staphylococcus aureus, tetanus and even anthrax are among the nasties that drug users are at increased risk of contracting.

 

While the sharing of needles is the cause of many of these infections, you don’t have to indulge in that particularly unwise behavior to end up with a potentially fatal infection.

 

Reusing your own needles, or injecting into a contaminated (dirty) arm, can easily introduce bacteria into the user’s system (including tetanus).

 


And in recent years, batches of heroin have been reported across Europe contaminated with anthrax spores, likely an unintentional contamination during the processing of the drug. 

 

This from the UK’s HPA earlier this week:

 

Case of anthrax confirmed in Oxford

2 November 2012

The Health Protection Agency (HPA) is aware that a person who injected heroin has been diagnosed with anthrax infection in Oxford. The patient is recovering.

 

This case has occurred after two people who injected drugs died from confirmed anthrax infection in Blackpool within a month of each other in August and September this year.

 

There is an ongoing outbreak of anthrax among people who inject drugs in a number of countries in Europe with 12 cases now identified since early June. The latest case in Oxford brings the total number affected in the UK to five – three in England (two fatal, one recovering), one in Scotland and one in Wales (both recovering).The source is presumed to be contaminated heroin.

(Continue . . . )

 

 

 

The HPA today has published a sobering report on the impact of infections associated with the injection of street drugs.  This is an update of a 2011 report, with an emphasis on Hepatitis B.

 

 

 

Shooting Up: Infections among people who inject drugs in the UK 2011. An update: November 2012

Shooting up: infections among people who inject drugs in the UK 2011: update Nov 2012 cover

Authors:

Health Protection Agency

Publication date: November 2012

Synopsis

  1. Hepatitis B infection among people who inject drugs has declined over the last decade. One in six people who inject drugs had ever been infected with the hepatitis B virus in 2011.
  2. This decline most probably reflects the marked increase in the uptake of the hepatitis B vaccine among people who inject drugs. Targeting vaccination to this group needs to be maintained if the current low level of new infections is to be sustained.
  3. Other infections remain common among people who inject drugs in the UK. Around half have been infected with hepatitis C, and around one in every 100 has HIV. 
  4. Bacterial infections remain a problem among people who inject drugs, with almost one-third reporting a symptom of a bacterial infection (such as a sore or abscess) at an injecting site in the past year. 
  5. Needle and syringe sharing is lower than a decade ago, although around one-sixth of people who inject drugs continue to share needles and syringes.

Download full publication

Infections among people who inject drugs in the UK 2011 An update: November 2012 (PDF, 1.7 MB)

 

 

While this report is UK specific, the UK has no corner on these types of infections among injectable drug users.

»» Read More

The UK’s Whooping Cough Outbreak

image

Confirmed Pertussis England & Wales by year & Quarter - 2012 numbers through 2nd Quarter

 

# 6661

 

Pertussis, or `Whooping Cough’ is a highly contagious bacterial infection that can cause serious illness and even death.  Although it is thought of as a `childhood’ disease, anyone of any age can catch it.

 

It is caused by either Bordetella pertussis or Bordetella parapertussis bacteria, which are easily spread through the air by the characteristic violent coughing spasms it induces. Infection can last for 6 weeks or longer, which is why it is sometimes called the `100 days' cough’.

 

Whooping cough in England and Wales, just as we’ve seen recently in the United States (see The Never Ending Battle), is on the rise again after two very successful decades of control.

 

image

The chart above (from Accelerating Control of Pertussis in England and Wales – EID Journal Vol. 18, No. 1, January 2012) illustrates just how well their vaccination program worked in controlling this disease since its introduction in the mid-1940s.

 

From seeing 170,000+ cases a year before the vaccine was introduced, down to triple digits in the early 1970s, the Pertussis vaccination in England & Wales has been a huge success story.

 

While spikes in cases did occur in the 1980s, increased uptake of the vaccine brought those numbers down again by 1990.

 

The reasons behind this latest spike in Pertussis cases are complex, and not completely understood, but some factors may include:

 

  • lower vaccination uptakes
  • the move away from whole cell pertussis vaccines to safer – but less broadly protective  - acellular vaccines in the 1990s
  • evolutionary changes in the Bordetella pertussis bacteria.

 

Recent evidence published in the NEJM suggests that protection from the newer acellular pertussis vaccine – introduced in the early 1990s – may wane sooner than previously suspected. 

 

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

Nicola P. Klein, M.D., Ph.D., Joan Bartlett, M.P.H., M.P.P., Ali Rowhani-Rahbar, M.D., M.P.H., Ph.D., Bruce Fireman, M.A., and Roger Baxter, M.D.

N Engl J Med 2012; 367:1012-1019 September 13, 2012DOI: 10.1056/NEJMoa1200850

 

 

All of which brings us to an HPA press release this morning, indicating that more than 6,000 whooping cough cases have been reported through the end of September, and urging parents to follow the recommended Pertussis vaccination schedule for their kids.

.

 

Whooping cough outbreak continues

25 October 2012

According to figures published by the Health Protection Agency (HPA) today, 1,322 cases of whooping cough (pertussis) were reported in England and Wales in September 2012, bringing the total number of cases so far this year to 6,121*.

 

The total number of cases so far in 2012 (up to end of September) is more than five times higher than the annual total number of cases reported in 2011 (1,118) and almost seven times higher than the total in 2008 (902) – the last ‘peak’ year before this current outbreak. In September there was one pertussis-related death in an infants under three months of age, bringing the total number of deaths in this age group so far this year to ten.

 

<SNIP>

 

“The introduction of a vaccine for pregnant women will not have an immediate impact on serious infection in infants so vigilance remains important. Working with the Department of Health we will continue to regularly monitor figures to evaluate the success of the programme.

 

“All parents should ensure their children are vaccinated against whooping cough on time, even babies of women who’ve had the vaccine in pregnancy – this is to continue their baby’s protection through childhood. Parents should also be alert to the signs and symptoms of whooping cough – which include severe coughing fits accompanied by the characteristic “whoop” sound in young children but as a prolonged cough in older children or adults. It is also advisable to keep babies away from older siblings or adults who have the infection.”

 

(Continue . . . )

 

 

This rise in Pertussis isn’t just a problem in the UK.

 

The Untied States saw a major upsurge in 2010, with more than 27,000 Whooping cough cases reported. Earlier this year the State of Washington declared a Pertussis epidemic (see MMWR Pertussis Epidemic — Washington, 2012).

 

And Australia has a record 38,500 cases (out of a population of just over 22 million) reported in 2011.

 

While admittedly not 100% perfect, the Pertussis vaccine remains the best way to prevent Whooping Cough.

 

For more on how to protect yourself, your family, and your community, the  CDC offers the following advice on Pertussis Vaccination.

 

Pertussis Vaccination

The best way to prevent pertussis is to get vaccinated. There are vaccines for infants, children, preteens, teens and adults. The childhood vaccine is called DTaP, and the pertussis booster vaccine for adolescents and adults is called Tdap. Talk to your healthcare provider about getting vaccinated against pertussis and read more about pertussis prevention.
For Those Getting Vaccinated
Pertussis Vaccine Basics
Offers comprehensive offers information about pertussis vaccines and other educational tools.
Td or Tdap Vaccine "What You Need To Know"Adobe PDF file (66 KB, 2 pages)
This one-page CDC vaccine information statement explains who should get Td or Tdap vaccine and when.
DTaP Vaccine "What You Need To Know"Adobe PDF file (58 KB, 2 pages)
This one-page CDC vaccine information statement explains who should get DTaP vaccine and when.
Vaccine Safety
Who Should Not Be Vaccinated with DTaP or Td-Tdap?
»» Read More

Update: CCHF Patient In Scotland Dies

 

image

Global Distribution of CCHF – Credit WHO

 

# 6612

 

News this morning from the UK press that the 38-year old man who flew into Glasgow, Scotland earlier this week from the Middle East infected with CCHF (see Crimean-Congo Hemorrhagic Fever Patient Isolated In Glasgow) has died overnight.

 

This report from the Independent, after which, I’ll have more.

 

Patient with rare fever dies in UK hospital

Lucinda Cameron  - Saturday 06 October 2012

A man being treated for Crimean-Congo haemorrhagic fever after returning to the UK from Afghanistan has died.

 

It is the first laboratory-confirmed case of CCHF in the UK, according to the Health Protection Agency (HPA).

 

Other passengers who sat close to him on an aircraft are undergoing daily health checks.

(Continue . . . )

 

 

Although originally hospitalized at Gartnavel General Hospital's Brownlee Centre, the unidentified patient was transferred yesterday to a high bio-security unit at London's Royal Free Hospital yesterday.

 

The following statement from the HPA was released yesterday, before the patient’s death.

 

Confirmed case of Crimean Congo Haemorrhagic Fever in the UK

5 October 2012

The Health Protection Agency (HPA) is aware of a laboratory confirmed case of Crimean-Congo Haemorrhagic Fever (CCHF) in a UK traveller who has recently returned from Afghanistan. The patient has been transferred from Glasgow, Scotland to the high security infectious diseases unit at the Royal Free hospital in London using specialist air transport.

CCHF is a serious viral disease which infects a range of domestic and wild animals. Humans are usually infected directly from the blood or body fluids of infected animals or via tick bites. The disease is endemic in many countries in Africa, parts of Europe, the Middle East and Asia.

CCHF can be acquired from an infected patient, but this requires direct contact with their blood or body fluids Therefore, there is no risk to the general population. As a precautionary measure, close contacts of the patient including hospital staff involved in the patient’s care have been contacted and will be monitored.

The HPA is providing public health, diagnostic and other support to the teams currently handling this incident.

This is the first laboratory-confirmed case of CCHF in the United Kingdom.

  • Information about the Crimean-Congo Haemorrhagic Fever is available on the HPA website. 
  • Information about the geographical distribution of CCHF is available on the HPA website.
  • Further information about the transmission of CCHF is available on the HPA website.
  • Information on CCHF is available from the World Health Organization (WHO) website [external link].
  • Visit the Royal Free Hospital website [external link].
  •  

    While the risk that this virus has been spread to others is considered low, the HPA will monitor close contacts of this patient for the next two weeks looking for any signs of infection.

    »» Read More

    HPA Letter To NHS Staff On Coronavirus

     image

     SARS coronavirus – Credit CDC PHIL

     

     

    # 6584

     

    Although it actually went out to GPs yesterday (Sept 25th), the HPA has today published the letter they sent to NHS staff in England and Scotland on the coronavirus case being treated at a London hospital.

     

    This letter provides us with perhaps the most detailed account to date on the events surrounding this case, including contact tracing.

     

     

    Patient receiving treatment for novel coronavirus

    26 September, 2012

    The Department of Health has issued an alert to advise of a case of a novel coronavirus in a patient receiving treatment in a London hospital.

     

    On 22 September 2012 a novel coronavirus was identified in lower respiratory tract specimens of a previously well, adult male Qatari national receiving treatment for a severe respiratory illness in London.

    Please see the full alert from the Department of Health

     

    Publication title: Novel coronavirus in a Qatari national receiving treatment for a severe respiratory illness in London

    Document type: Letter

    Publication description: This is to advise of a case of a novel coronavirus in a patient receiving treatment in a London hospital.

    Publication author: Department of Health

    Copyright holder: Crown

    DH Gateway number: 18180

    Date of publication: 26 September, 2012

    Series number: CEM/CMO/2012/15

    Some excerpts from the letter (slightly reformatted for readability) include:

    NOVEL CORONAVIRUS IN A QATARI NATIONAL RECEIVING TREATMENT FOR A SEVERE RESPIRATORY ILLNESS IN LONDON

    On 22 September 2012 a novel coronavirus was identified in lower respiratory tract specimens of a previously well, adult male Qatari national receiving treatment for a severe respiratory illness in London. The virus is virtually identical genetically to a novel coronavirus recently identified by Dutch researchers in a clinical sample from a Saudi Arabian national who was ill with pneumonia over three months ago. These are currently the only two known cases from whom this virus has been isolated.

     

    Coronaviruses are causes of the common cold but also include the virus responsible for SARS.  Strict respiratory isolation has been instituted around the current case and all personnel caring for the patient are wearing the appropriate personal protective clothing.

     

    Respiratory symptoms in the current case started in early September after a reported visit to Saudi Arabia. The patient was admitted to hospital in Qatar and, as symptoms worsened, was transferred to London by air ambulance on 11 September where he is now being treated in intensive care.

     

    Initial routine investigations revealed no cause for the illness but on 21 September, following a report in ProMED describing the identification of a novel human coronavirus, in a fatal respiratory illness in an adult Saudi Arabian national, specimens from the London patient were examined for coronavirus infection, and were found to be positive.Genetic characterisation of the virus revealed that it was virtually identical to the virus that caused the illness in the earlier case from Saudi Arabia.

     

    In the light of the severity of the illness in the two confirmed cases and the novel nature of the virus, contacts of the cases, predominantly health care workers, are being contacted to ensure they are well and that further transmission has not occurred. 

     

    Follow up of the contacts of the current case is underway; no illness due to this infection has been confirmed so far in this group. Many of these contacts are already likely to be beyond the incubation period (currently assumed to be seven
    days, based on what is known about other human coronavirus infections) when symptoms would have developed had they been infected. No other cases of confirmed or probable infection with this virus.

     

    Information about these cases, and advice on the need to be vigilant for the possibility of further cases, has been developed for health care workers in the UK. 


    http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/RespiratoryViruses/NovelCoronavirus/respinfoforprofnovelcoronavirussept2012/  

     

    »» Read More

    UK: HPA Announcement On Novel Coronavirus Case

     

     image

    Credit Wikipedia

     

     

    # 6572

     

    The news is now coming at a faster pace on the novel coronavirus cases announced this morning by Saudi Arabia (see Details Emerge On (3) Saudi Coronavirus Cases).

     

    The HPA has now confirmed that one case, indeed, has travelled to the UK and is being treated, while another patient in the UK that died recently is being investigated (but has not been proven to have the same virus).

     

    It appears, however, that these cases have not all just suddenly emerged, but rather have been popping up (along with scattered reports of other serious respiratory illnesses in the Mideast, now under investigation) for several months.

     

    This from the HPA.

     

    Acute respiratory illness associated with a new virus identified in the UK

    23 September 2012

    The Health Protection Agency (HPA) can confirm the diagnosis of one laboratory confirmed case of severe respiratory illness associated with a new type of coronavirus. The patient, who is from the Middle East and recently arrived in the UK, is receiving intensive care treatment in a London hospital.

     

    In recent months, this new human coronavirus was also identified in a patient with acute respiratory illness in Saudi Arabia, who subsequently died.

     

    Coronaviruses are causes of the common cold but can also include more severe illness, such as the virus responsible for SARS (Severe Acute Respiratory Syndrome). This new virus, however, is different from any that have previously been identified in humans. Preliminary enquiries have revealed no evidence of illness in contacts of these two cases, including healthcare workers. Based on what we know about other coronaviruses, many of these contacts will already have passed the period when they could have caught the virus from the infected person.

     

    We are also aware of a small number of other cases of serious respiratory illness in the Middle East in the past three months, one of whom was treated in the UK but has since died. This person's illness is also being investigated although there is no evidence at present to suggest that it is caused by the same virus or linked to the other two cases. No other confirmed cases have been identified to date in the UK

     

     

    Professor John Watson, head of the respiratory diseases department at the HPA, said: "The HPA is providing advice to healthcare workers to ensure the patient under investigation is being treated appropriately.

     

    "In the light of the severity of the illness that has been identified in the two confirmed cases, immediate steps have been taken to ensure that people who have been in contact with the UK case have not been infected, and there is no evidence to suggest that they have.

     

    "Further information about these cases is being developed for healthcare workers in the UK, as well as advice to help maintain increased vigilance for this virus. This information is also being shared with national and international authorities including the World Health Organization and the European Centre for Disease Control.

     

    "As we are aware of only two cases worldwide and there is no specific evidence of ongoing transmission, at present there is no specific advice for the public or returning travellers to take but we will share any further advice with the public as soon as more information becomes available."

    »» Read More

    UK: HPA Takes Notice Of H3N2v

     

    image

    Photo Credit CDC

     

     

    # 6505

     

    Although no cases of human H3N2v infection have been reported outside of the United States, other nations are understandably watching the situation closely, and are preparing for the possibility of seeing this flu virus imported into their region.


    Last week Hong Kong made H3N2v a reportable disease (see Hong Kong Takes Notice Of H3N2v), while the ECDC published a risk assessment on the virus last Friday (see H3N2v: CDC Update & ECDC Risk Assessment).

     

     

    Although the threat from this virus is considered low at this time, today the HPA published recommendations that travelers returning from the United States with `an influenza-like illness who have had contact with pigs in the USA within five days of the onset of their illness, should be investigated further’.

     

     

    Update on new swine flu in the US

    21 August 2012

    The Health Protection Agency (HPA) is aware there have been nearly 250 human cases of swine-origin influenza A(H3N2)v virus in the recent USA outbreak since it was first identified in August 2011.

     

    The virus has mainly affected children and young adults and is mild in nature. Most cases have documented contact with pigs, although in one small cluster of six cases reported in December 2011, there may have been limited human to human transmission. This virus has not been identified in pigs or humans in the UK.

     

    The HPA has recommended that returning travellers with an influenza-like illness who have had contact with pigs in the USA within five days of the onset of their illness, should be investigated further. The HPA is contacting GPs to ensure they are aware of this recommendation in light of this outbreak and we are updating the website with information on this new strain.

     

    The US Centre for Disease Control and Prevention (CDC) has advised this summer that in the US, those at increased risk of the complications of influenza, including older people, small children and those with chronic diseases, should consider avoiding pigs and swine barns.

     

    The strain of H3N2 in the current seasonal flu vaccine is different to the A(H3N2)v although, since the virus is related to the human H3N2 influenza virus that was circulating in the 1990s, studies suggest that adults may have some immunity to this virus whereas children will not.

     

    Professor Nick Phin, from the HPA’s influenza department said:

     

    “There are no UK cases of this strain of H3N2 in humans or pigs and it has not spread to other countries in Europe, so the threat to the UK public is very low. We are keeping a very close watch on the situation in the US and are in contact with our American colleagues to regularly assess the risk.

     

    “We are reassured that there is little evidence to support human to human spread and that virtually all of the cases can be associated with direct contact with pigs.

     

    “We are now approaching this year’s flu season and so I want to take this opportunity to remind anybody who is in an ‘at risk’ group to ensure they get their flu vaccination as soon as the vaccination programme begins to ensure the best protection over the coming winter.”

    (Continue . . .)

    »» Read More

    UK: Probable Source Of Legionnaires Outbreak Indentified

    image

    Legionella Bacteria - Photo Credit CDC PHIL

     

    # 6461

     

    The outbreak of Legionella in the UK I wrote about last week (see HPA Updates The Stoke-On-Trent Legionella Outbreak) has expanded to 18 cases, and today the HPA has announced that they believe they have tracked down the bacteria’s source.

     

    It appears that 17 of the 18 cases visited a JTF Mega Discount Warehouse where hot tubs were displayed and sold.  Genetic fingerprinting has determined that the same strain of Legionella found in these patients was present in the hot tub.

     

    As this was a unique strain, not previously encountered, the odds are pretty good they’ve found the source.

     

    The legionella bacteria thrives in warm water, such as is often found in air-conditioning cooling towers, hot tubs, and even ornamental water fountains. Improper maintenance, or poor design, can lead to the bacteria blooming.

     

    When aerated the bacteria can become airborne, and if inhaled by a susceptible host, can cause a serious (and sometimes fatal) form of pneumonia. 

     

    This update comes from the HPA.

     

     

    Stoke-on-Trent Legionnaires’ Disease Outbreak – probable source identified

    30 July 2012

    Public and environmental health experts investigating the Legionnaires’ disease outbreak at Stoke-on-Trent believe they have identified a probable source.

     

    The probable source is a hot tub based at JTF Warehouse, City Road, Fenton, Stoke-on-Trent. We would like to emphasise that investigations are still ongoing. Environmental Health specialists from the Health and Safety Executive and Stoke-on-Trent City Council have taken and continue to take samples from sites across Stoke.

     

    A spokesperson from the Health and Safety Executive said: "HSE continues to inspect premises where we are the enforcing authority and will do so until we have eliminated those sites from our investigations and are sufficiently assured there are no other possible sources."

     

    The samples from the hot tub at JTF Warehouse were confirmed by the Health Protection Agency’s specialist laboratory in Colindale last night as being an unusual strain legionella bacteria. The strain matched those taken from patients. JTF warehouse are fully cooperating with the investigation.

     

    Dr Sue Ibbotson, regional director, Health Protection Agency West Midlands said: “We have identified the probable source of the Legionnaires' disease outbreak in Stoke. We have the evidence from DNA fingerprinting of samples from the hot tub and the patients being caused by the same previously unseen strain of legionella. The HPA also took detailed histories from the confirmed cases and we know that 17 of the 18 confirmed cases visited this warehouse in the two weeks before they fell ill. Added to that we know that spa pools are known to be effective mechanisms for spreading legionella infection.

     

    “We may still expect to see new cases of Legionnaires’ disease related to this outbreak. JTF Warehouse decommissioned the hot tub on 24 July. It can take up to two weeks following exposure for people to develop symptoms of Legionnaires’ disease and a further few days before they go to see their GP. We continue to work with our partners to investigate this outbreak and continue to take samples across the city in case there are other sites with the same strain of legionnella.”

    (Continue . . . )

     


    For an even more unusual source of Legionella, you may wish to revisit a blog from 2010 where we looked at a Study: Wiper Fluid And Legionella.

    »» Read More

    HPA Updates The Stoke-On-Trent Legionella Outbreak

     

    image

    Legionella Bacteria - Photo Credit CDC PHIL

    # 6450

     

    Yesterday Crof reported on the UK: Legionnaires' disease outbreak in Stoke-on-Trent that involved 7 patients hailing from that city in Staffordshire, England.

     

    Today, we’ve an update from the HPA indicates that two more cases have been identified, and that early microbiology testing is consistent with there being an (as yet, unidentified) common source.

     

     

    3.00pm update on Legionnaires' disease in Stoke-on-Trent

    25 July 2012

    Two further case of Legionnaires' disease have been confirmed in the Stoke-on-Trent outbreak bringing the total number of cases to nine. All those affected are between their late 40s and mid 70s and are being treated at University Hospital of North Staffordshire. The Health Protection Agency (HPA) is also investigating two cases identified in early summer as being possibly linked to the current cluster.

     

    Professor Harsh Duggal, Director of the Health Protection Unit in Stafford, said: “Early microbiology typing results back from the HPA laboratories show that samples taken from some of the patients look very similar so far and this is consistent with the cases having caught their infection from the same environmental source. We are taking detailed histories of the movements of the patients to see if there are similar patterns which would indicate a local source of infection.

    (Continue . . . )

     

     

    While an infectious pneumonia, Legionella is not a contagious disease.  It is transmitted environmentally, usually through water.

     

    Legionella got it’s name after it was identified as the bacterial cause of a large pneumonia outbreak at Philadelphia’s Bellevue Stratford Hotel during an American Legion convention in 1976.

     

    During this outbreak, 221 people were treated and 34 died.

     

    We now know Legionella to be a major cause of infectious pneumonia, and that it can sometimes spark large outbreaks of illness.  According to the CDC between 8,000 and 18,000 Americans are hospitalized with Legionnaire's Disease each year, although many more milder cases likely occur.

     

    For more information on the disease, the CDC maintains a fact sheet at Patient Facts: Learn More about Legionnaires' disease.

    The bacteria thrives in warm water, such as is often found in air-conditioning cooling towers, hot tubs, and even ornamental water fountains. Improper maintenance or poor design can lead to the bacteria blooming.

     

    When water is sprayed into the air the bacteria can become airborne, and if inhaled by a susceptible host, can cause a serious (and sometimes fatal) form of pneumonia.

     

    While large outbreaks of Legionella are often traced to specific causes, quite often the source of the infection for sporadic cases remains a mystery.  

     

    Today’s HPA announcement stresses that these cases are not hospital acquired, and that the authorities are working to identify the source.

    »» Read More

    More Tales From The Crypto

     

     


    # 6375

     

     

    A little more than a week ago, in Tales From The Crypto, I wrote about an HPA (Health Protection Agency) investigation into an unusually large number of gastrointestinal illnesses being reported across England due to the Cryptosporidium parasite, or as it is commonly called, “Crypto”.

     

    Over the past 7 days another 60 people have been diagnosed with this (generally) waterborne illness from the four regions of the North East, Yorkshire, West Midlands and East Midlands, bringing the total since early May to 327 (compared to 82 during the same period in 2011).

     

    While still elevated above normal, the number of new cases over the past week is less than was seen during the previous two weeks, and not all of these may be attributed to this outbreak.

     

    It is too soon to know if this outbreak has peaked.

     

    The source of infection has yet to be identified. Local water authorities reassure that there is no evidence of contamination of the public water supply.

     

    While generally thought of a waterborne illness, Crypto may be found in soil, food, water, or on surfaces that have been contaminated with the feces from infected humans or animals.

     

    image

    Photo Credit CDC PHIL

     

    Here is the latest Health Protection Agency update on the Crypto outbreak, followed by some prevention advice from the CDC.

     

    Update 8 June: Increase in cases of cryptosporidiosis

    8 June 2012

    The Health Protection Agency (HPA) continues to lead a multi-agency investigation to determine whether recent cases of cryptosporidiosis are linked to a common source.

     

    The English regions most affected by the increase in cases continue to be the North East, Yorkshire, West Midlands and East Midlands. An additional 60 cases of cryptosporidiosis have been confirmed across the four regions between 01 June and 07 June 2012, taking the total number of cases confirmed in these regions since 11 May 2012 to 327. This compares to 82 cases of the infection confirmed across the four regions within the same period the previous year (11 May 2011 to 07 June 2011).

     

    Most people affected had a mild to moderate form of illness and the HPA is not aware that any cases reported in the past week (since 1 June) have been hospitalised.

     

    So far investigations have not identified a likely source of infection. The Drinking Water Inspectorate has confirmed that there is currently no evidence that public water supplies are implicated.

     

    Cryptosporidiosis is caused by an organism called Cryptosporidium, which is found in soil, food, water or surfaces that have been contaminated with infected human or animal droppings. People can become infected by consuming contaminated water or food, by swimming in contaminated water, for example in lakes or rivers, or through contact with infected animals. The most common symptom is diarrhoea, which can range from mild to severe.

     

    Dr Stephen Morton, who is leading the investigation for the HPA, said: “The latest figures show that the sudden upturn in cases seen in May 2012 has not continued into the first week of June. The majority of cases became ill between 11 and 18 May. Whilst the increase is higher than we might expect at this time of year, it is not unusual to see an increase in cryptosporidiosis cases in the early summer and not all of the cases reported since 11 May are likely to be linked.

    (Continue . . . )

     

    Crypto infections occur around the globe, and according to an EID Journal study published last year, there are estimated to be nearly 750,000 Crypto infections in the United States each year (see Foodborne Illness Acquired in the United States—Major Pathogens).

     

    For most healthy individuals, a Crypto infection is an unpleasant, but not life threatening illness.  The most common symptoms (which generally last 1 to 2 weeks) are:

     

    • Watery Diarrhea
    • Stomach cramps or pain
    • Dehydration
    • Nausea
    • Vomiting
    • Fever
    • Weight loss

     

    Although rarely fatal in healthy individuals, `Crypto’ can be deadly for the very young, the very old, and those with compromised immune systems.

     

     


    All of which makes prevention key.  The CDC gives the following advice to reduce exposure to Crypto.

     

    Practice Good Hygiene
    Everywhere
    • Wash hands with soap and water for at least 20 seconds, rubbing hands together vigorously and scrubbing all surfaces:
      • Before preparing or eating food
      • After using the toilet
      • After changing diapers or cleaning up a child who has used the toilet
      • Before and after tending to someone who is ill with diarrhea
      • After handling an animal or animal waste
    At child care facilities
    • To reduce the risk of disease transmission, children with diarrhea should be excluded from child care settings until the diarrhea has stopped.
    At recreational water venues (pools, interactive fountains, lakes, ocean)
    • Protect others by not swimming if you are experiencing diarrhea (this is essential for children in diapers). If diagnosed with cryptosporidiosis, do not swim for at least 2 weeks after diarrhea stops.
    • Shower before entering the water.
    • Wash children thoroughly (especially their bottoms) with soap and water after they use the toilet or their diapers are changed and before they enter the water.
    • Take children on frequent bathroom breaks and check their diapers often.
    • Change diapers in the bathroom, not at the poolside.
    Around animals
    • Minimize contact with the feces of all animals, particularly young animals.
    • When cleaning up animal feces, wear disposable gloves, and always wash hands when finished.
    • Wash hands after any contact with animals or their living areas.
    Outside
    • Wash hands after gardening, even if wearing gloves.

    »» Read More